Literature DB >> 19462317

The washouts of discarded bone marrow collection bags and filters are a very abundant source of hMSCs.

Chiara Capelli1, Agnese Salvade, Olga Pedrini, Valentina Barbui, Elisa Gotti, Gianmaria Borleri, Benedetta Cabiati, Daniela Belotti, Paolo Perseghin, Piero Bellavita, Andrea Biondi, Ettore Biagi, Alessandro Rambaldi, Josee Golay, Martino Introna.   

Abstract

BACKGROUND AIMS: Human multipotent mesenchymal stromal cells (hMSC) are considered good candidates for a growing spectrum of cell therapies. We have validated a protocol that makes use of the washouts of discarded collection sets, left over at the end of the filtration of bone marrow (BM) explants performed for hematopoietic stem cell (HSC) transplantation.
METHODS: The method consists of direct plating of cells without density-gradient isolation followed by two detachment steps and expansion in 5% human platelet lysate (hPL).
RESULTS: In a median of 26 days, 14 bags for adult patients and nine bags for pediatric patients for a standard dose of 1x10(6) hMSC/kg body weight could be prepared from the expansion of a fraction of the cells recovered from seven independent washouts. Moreover, 151 vials could be frozen from the remaining cells. The theoretical full expansion of all the frozen vials (validated by the expansion of two independent vials) could have allowed the production of 173 bags for adults and 348 bags for pediatric patients.
CONCLUSIONS: The washouts of discarded bags and filters left over at the end of routine BM explants filtration are a very abundant source of hMSC precursors that can be easily utilized for clinical applications.

Entities:  

Mesh:

Year:  2009        PMID: 19462317     DOI: 10.1080/14653240902960437

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  8 in total

1.  Frequent occurrence of non-malignant genetic alterations in clinical grade mesenchymal stromal cells expanded for cell therapy protocols.

Authors:  Chiara Capelli; Olga Pedrini; Gisella Cassina; Orietta Spinelli; Silvia Salmoiraghi; Josée Golay; Alessandro Rambaldi; Ursula Giussani; Martino Introna
Journal:  Haematologica       Date:  2014-03-28       Impact factor: 9.941

2.  Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility.

Authors:  Norberto Perico; Federica Casiraghi; Martino Introna; Eliana Gotti; Marta Todeschini; Regiane Aparecida Cavinato; Chiara Capelli; Alessandro Rambaldi; Paola Cassis; Paola Rizzo; Monica Cortinovis; Maddalena Marasà; Josee Golay; Marina Noris; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-07       Impact factor: 8.237

3.  Mesenchymal stromal cells from donors varying widely in age are of equal cellular fitness after in vitro expansion under hypoxic conditions.

Authors:  Troy C Lund; Amanda Kobs; Bruce R Blazar; Jakub Tolar
Journal:  Cytotherapy       Date:  2010-08-31       Impact factor: 5.414

Review 4.  Myeloid and Mesenchymal Stem Cell Therapies for Solid Organ Transplant Tolerance.

Authors:  Jennifer Li; Angus W Thomson; Natasha M Rogers
Journal:  Transplantation       Date:  2021-12-01       Impact factor: 5.385

5.  Multipotent mesenchymal stromal stem cell expansion by plating whole bone marrow at a low cellular density: a more advantageous method for clinical use.

Authors:  Katia Mareschi; Deborah Rustichelli; Roberto Calabrese; Monica Gunetti; Fiorella Sanavio; Sara Castiglia; Alessandra Risso; Ivana Ferrero; Corrado Tarella; Franca Fagioli
Journal:  Stem Cells Int       Date:  2011-10-15       Impact factor: 5.443

6.  Pathogen-free, plasma-poor platelet lysate and expansion of human mesenchymal stem cells.

Authors:  Paola Iudicone; Daniela Fioravanti; Giuseppina Bonanno; Michelina Miceli; Claudio Lavorino; Pierangela Totta; Luigi Frati; Marianna Nuti; Luca Pierelli
Journal:  J Transl Med       Date:  2014-01-27       Impact factor: 5.531

7.  Intravenous infusion of human bone marrow mesenchymal stromal cells promotes functional recovery and neuroplasticity after ischemic stroke in mice.

Authors:  Eliana Sammali; Claudia Alia; Gloria Vegliante; Valentina Colombo; Nadia Giordano; Francesca Pischiutta; Giorgio B Boncoraglio; Mario Barilani; Lorenza Lazzari; Matteo Caleo; Maria-Grazia De Simoni; Giuseppe Gaipa; Giuseppe Citerio; Elisa R Zanier
Journal:  Sci Rep       Date:  2017-07-31       Impact factor: 4.379

8.  Long-Term Clinical and Immunological Profile of Kidney Transplant Patients Given Mesenchymal Stromal Cell Immunotherapy.

Authors:  Norberto Perico; Federica Casiraghi; Marta Todeschini; Monica Cortinovis; Eliana Gotti; Valentina Portalupi; Marilena Mister; Flavio Gaspari; Alessandro Villa; Sonia Fiori; Martino Introna; Elena Longhi; Giuseppe Remuzzi
Journal:  Front Immunol       Date:  2018-06-14       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.